Akoya Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

On August 31, 2021 Akoya Biosciences, Inc. (Nasdaq: AKYA) ("Akoya"), The Spatial Biology Company, reported that it will be virtually participating in the Morgan Stanley 19th Annual Global Healthcare Conference (Press release, Akoya Biosciences, AUG 31, 2021, View Sourcenews-releases/news-release-details/akoya-biosciences-present-morgan-stanley-19th-annual-global" target="_blank" title="View Sourcenews-releases/news-release-details/akoya-biosciences-present-morgan-stanley-19th-annual-global" rel="nofollow">View Source [SID1234590280]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Brian McKelligon, CEO, and Joe Driscoll, CFO, are scheduled to participate in a fireside chat on Monday, September 13th, 2021 at 5:00 p.m. ET.

A live webcast of the event will be available on the "Investors" section of the Akoya website at View Source and will be available for 90 days thereafter.